R-CHOP-话题@MedSci

#R-CHOP#

19篇内容 | 2220人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2255221, encodeId=cfe72255221bf, content=<a href='/topic/show?id=518761566e4' target=_blank style='color:#2F92EE;'>#来那度胺#</a> <a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a> <a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Blood Cancer J | 来那度胺联合R-CHOP（R2-CHOP）在新诊断的双表达弥漫大B细胞淋巴瘤中的应用, objectType=article, longId=865899, objectId=47a686589936, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719541210140_92910.jpg, objectUrl=/article/show_article.do?id=47a686589936, replyNumber=0, likeNumber=15, createdTime=2025-03-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=47a686589936, moduleTitle=Blood Cancer J | 来那度胺联合R-CHOP（R2-CHOP）在新诊断的双表达弥漫大B细胞淋巴瘤中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47a686589936)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2254210, encodeId=66782254210a7, content=<a href='/topic/show?id=c4a844521e5' target=_blank style='color:#2F92EE;'>#套细胞淋巴瘤#</a> <a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a>, objectTitle=初治不适合移植MCL，BR对比R-CHOP诱导（R维持）的疗效一致, objectType=article, longId=864825, objectId=e8158648250c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220801/1659324313353_8252897.webp, objectUrl=/article/show_article.do?id=e8158648250c, replyNumber=0, likeNumber=16, createdTime=2025-03-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=e8158648250c, moduleTitle=初治不适合移植MCL，BR对比R-CHOP诱导（R维持）的疗效一致, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8158648250c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2224634, encodeId=55b3222463409, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a> <a href='/topic/show?id=020f118843ed' target=_blank style='color:#2F92EE;'>#Richter转化#</a> <a href='/topic/show?id=066211e13968' target=_blank style='color:#2F92EE;'>#贝林妥欧单抗#</a>, objectTitle=【Nat Commun】R-CHOP序贯贝林妥欧单抗治疗Richter转化, objectType=article, longId=842208, objectId=5ce484220825, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240904/1725446887318_8538692.jpg, objectUrl=/article/show_article.do?id=5ce484220825, replyNumber=0, likeNumber=82, createdTime=2024-09-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5ce484220825, moduleTitle=【Nat Commun】R-CHOP序贯贝林妥欧单抗治疗Richter转化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ce484220825)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2200406, encodeId=e681220040627, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a> <a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a> <a href='/topic/show?id=e58d60299c' target=_blank style='color:#2F92EE;'>#DLBCL#</a>, objectTitle=【Cancer Med】各治疗线DLBCL的真实世界患者特征、治疗模式和结局, objectType=article, longId=823169, objectId=d3a6823169df, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=d3a6823169df, replyNumber=0, likeNumber=156, createdTime=2024-04-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=d3a6823169df, moduleTitle=【Cancer Med】各治疗线DLBCL的真实世界患者特征、治疗模式和结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3a6823169df)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190733, encodeId=9ba02190e3393, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a> <a href='/topic/show?id=adf366592da' target=_blank style='color:#2F92EE;'>#滤泡淋巴瘤#</a>, objectTitle=R-CHOP治疗晚期滤泡淋巴瘤的超15年随访结果, objectType=article, longId=812307, objectId=3ebc81230e6b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/busy-reception-in-a-hospital-with-doctors-and-PUPDEB8.jpg, objectUrl=/article/show_article.do?id=3ebc81230e6b, replyNumber=0, likeNumber=92, createdTime=2024-03-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3ebc81230e6b, moduleTitle=R-CHOP治疗晚期滤泡淋巴瘤的超15年随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ebc81230e6b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2188279, encodeId=609b21882e9cb, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a> <a href='/topic/show?id=e58d60299c' target=_blank style='color:#2F92EE;'>#DLBCL#</a>, objectTitle=【Cancer Treat Rev】DLBCL中改良R-CHOP的路线图, objectType=article, longId=813728, objectId=ecfb813e2824, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-is-working-at-the-hospital-PAJM2K5.jpg, objectUrl=/article/show_article.do?id=ecfb813e2824, replyNumber=0, likeNumber=97, createdTime=2024-02-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ecfb813e2824, moduleTitle=【Cancer Treat Rev】DLBCL中改良R-CHOP的路线图, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecfb813e2824)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2178750, encodeId=374421e87503a, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a> <a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=【Leukemia】诊断后两年内复发的DLBCL患者的遗传学和转录组学分析, objectType=article, longId=807775, objectId=6e3580e775e2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-doctor-review-PTX6YZP.jpg, objectUrl=/article/show_article.do?id=6e3580e775e2, replyNumber=0, likeNumber=107, createdTime=2024-01-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6e3580e775e2, moduleTitle=【Leukemia】诊断后两年内复发的DLBCL患者的遗传学和转录组学分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e3580e775e2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2175452, encodeId=dde121e545273, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a> <a href='/topic/show?id=adf366592da' target=_blank style='color:#2F92EE;'>#滤泡淋巴瘤#</a> <a href='/topic/show?id=62eae8968e3' target=_blank style='color:#2F92EE;'>#继发性恶性肿瘤#</a>, objectTitle=【BJH】R-CHOP治疗248例晚期滤泡淋巴瘤的15年随访结果, objectType=article, longId=805194, objectId=949580519461, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-conference-P42ZDP5.jpg, objectUrl=/article/show_article.do?id=949580519461, replyNumber=0, likeNumber=81, createdTime=2023-12-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=949580519461, moduleTitle=【BJH】R-CHOP治疗248例晚期滤泡淋巴瘤的15年随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=949580519461)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1456601, encodeId=b7311456601b4, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a>, objectTitle=ESMO 2022：奥布替尼联合R-CHOP治疗既往未经治疗的non-GCB DLBCL患者的疗效和安全性, objectType=article, longId=739080, objectId=9bbfe3908038, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bbfe3908038, replyNumber=0, likeNumber=111, createdTime=2022-09-13, rootId=0, userName=xiongliangxl, userId=ed1f5772106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bbfe3908038, moduleTitle=ESMO 2022：奥布替尼联合R-CHOP治疗既往未经治疗的non-GCB DLBCL患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bbfe3908038)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1456600, encodeId=652e145660033, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a>, objectTitle=J Clin Oncol：3期| 来那度胺联合R-CHOP方案治疗ABC型DLBCL的疗效和安全性, objectType=article, longId=210513, objectId=1f42210513fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f42210513fc, replyNumber=0, likeNumber=90, createdTime=2021-04-28, rootId=0, userName=xiongliangxl, userId=ed1f5772106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f42210513fc, moduleTitle=J Clin Oncol：3期| 来那度胺联合R-CHOP方案治疗ABC型DLBCL的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f42210513fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1456599, encodeId=e4a6145659926, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a>, objectTitle=JCO：来那度胺+R-CHOP联合治疗未能显著改善ABC型DLBCL的PFS, objectType=article, longId=207552, objectId=b86b20e552cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b86b20e552cf, replyNumber=0, likeNumber=81, createdTime=2021-02-26, rootId=0, userName=xiongliangxl, userId=ed1f5772106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b86b20e552cf, moduleTitle=JCO：来那度胺+R-CHOP联合治疗未能显著改善ABC型DLBCL的PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b86b20e552cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1456598, encodeId=329e145659834, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a>, objectTitle=J Clin Oncol：R-CHOP方案+来那度胺可进一步改善新确诊DLBCL患者预后, objectType=article, longId=207043, objectId=91d820e04381, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91d820e04381, replyNumber=0, likeNumber=100, createdTime=2021-02-12, rootId=0, userName=xiongliangxl, userId=ed1f5772106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91d820e04381, moduleTitle=J Clin Oncol：R-CHOP方案+来那度胺可进一步改善新确诊DLBCL患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91d820e04381)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1456597, encodeId=d03f145659e41, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a>, objectTitle=JCO：来那度胺联合R-CHOP治疗可延长未经治疗的弥漫性大B细胞淋巴瘤患者的生存期, objectType=article, longId=207011, objectId=dcad20e01104, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcad20e01104, replyNumber=0, likeNumber=87, createdTime=2021-02-11, rootId=0, userName=xiongliangxl, userId=ed1f5772106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcad20e01104, moduleTitle=JCO：来那度胺联合R-CHOP治疗可延长未经治疗的弥漫性大B细胞淋巴瘤患者的生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dcad20e01104)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1456596, encodeId=dde214565961e, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a>, objectTitle=Blood：采用R-CHOP治疗的原发性纵隔大B细胞淋巴瘤(PMBCL) 的预后, objectType=article, longId=197418, objectId=96e319e4187d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96e319e4187d, replyNumber=0, likeNumber=90, createdTime=2020-07-14, rootId=0, userName=xiongliangxl, userId=ed1f5772106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96e319e4187d, moduleTitle=Blood：采用R-CHOP治疗的原发性纵隔大B细胞淋巴瘤(PMBCL) 的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96e319e4187d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1456595, encodeId=be051456595d8, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a>, objectTitle=Clin cancer research：EPZ-6438联合R-CHOP治疗弥漫性大B细胞淋巴瘤, objectType=article, longId=197011, objectId=7c6419e01122, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c6419e01122, replyNumber=0, likeNumber=102, createdTime=2020-07-05, rootId=0, userName=xiongliangxl, userId=ed1f5772106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c6419e01122, moduleTitle=Clin cancer research：EPZ-6438联合R-CHOP治疗弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c6419e01122)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1456594, encodeId=def314565948d, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a>, objectTitle=Lancet oncol：R-CHOP联合甲氨蝶呤和鞘内化疗治疗新确诊的IVLBCL的疗效和安全性, objectType=article, longId=190230, objectId=fcd3190230c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcd3190230c9, replyNumber=0, likeNumber=81, createdTime=2020-03-19, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcd3190230c9, moduleTitle=Lancet oncol：R-CHOP联合甲氨蝶呤和鞘内化疗治疗新确诊的IVLBCL的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcd3190230c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1456593, encodeId=707c1456593d1, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a>, objectTitle=Lancet：R-CHOP化疗联合利妥昔单抗治疗侵袭性B细胞非霍奇金淋巴瘤, objectType=article, longId=185002, objectId=956e185002ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=956e185002ad, replyNumber=0, likeNumber=96, createdTime=2019-12-22, rootId=0, userName=xiongliangxl, userId=ed1f5772106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=956e185002ad, moduleTitle=Lancet：R-CHOP化疗联合利妥昔单抗治疗侵袭性B细胞非霍奇金淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=956e185002ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1456592, encodeId=ef18145659232, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a>, objectTitle=王亮教授：R-CHOP一线治疗DLBCL——一直被挑战，至今从未被超越！, objectType=article, longId=169070, objectId=3a321690e0a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a321690e0a2, replyNumber=0, likeNumber=77, createdTime=2019-06-26, rootId=0, userName=xiongliangxl, userId=ed1f5772106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a321690e0a2, moduleTitle=王亮教授：R-CHOP一线治疗DLBCL——一直被挑战，至今从未被超越！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a321690e0a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1456591, encodeId=63821456591db, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a>, objectTitle=Blood：Venetoclax联合R-CHOP可安全有效治疗弥漫性大B细胞淋巴瘤, objectType=article, longId=162820, objectId=0e731628209a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e731628209a, replyNumber=0, likeNumber=74, createdTime=2019-03-25, rootId=0, userName=xiongliangxl, userId=ed1f5772106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e731628209a, moduleTitle=Blood：Venetoclax联合R-CHOP可安全有效治疗弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e731628209a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1456590, encodeId=7b17145659077, content=<a href='/topic/show?id=f76e15029a7' target=_blank style='color:#2F92EE;'>#R-CHOP#</a>, objectTitle=Lancet Haematol：R-CHOP作为新确诊晚期滤泡性淋巴瘤患者一线治疗怎么样？, objectType=article, longId=155657, objectId=637315565e43, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=637315565e43, replyNumber=0, likeNumber=94, createdTime=2018-12-14, rootId=0, userName=xiongliangxl, userId=ed1f5772106, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=637315565e43, moduleTitle=Lancet Haematol：R-CHOP作为新确诊晚期滤泡性淋巴瘤患者一线治疗怎么样？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=637315565e43)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

R-CHOP

2020-05-29

梅斯管理员

#来那度胺# #R-CHOP# #弥漫性大B细胞淋巴瘤#

Blood Cancer J | 来那度胺联合R-CHOP（R2-CHOP）在新诊断的双表达弥漫大B细胞淋巴瘤中的应用

2025-03-08发表于陕西省

梅斯管理员

#套细胞淋巴瘤# #R-CHOP#

初治不适合移植MCL，BR对比R-CHOP诱导（R维持）的疗效一致

2025-03-02发表于陕西省

梅斯管理员

#R-CHOP# #Richter转化# #贝林妥欧单抗#

【Nat Commun】R-CHOP序贯贝林妥欧单抗治疗Richter转化

2024-09-08发表于上海

梅斯管理员

#R-CHOP# #弥漫性大B细胞淋巴瘤# #DLBCL#

【Cancer Med】各治疗线DLBCL的真实世界患者特征、治疗模式和结局

2024-04-25发表于陕西省

梅斯管理员

#R-CHOP# #滤泡淋巴瘤#

R-CHOP治疗晚期滤泡淋巴瘤的超15年随访结果

2024-03-03发表于上海

梅斯管理员

#R-CHOP# #DLBCL#

【Cancer Treat Rev】DLBCL中改良R-CHOP的路线图

2024-02-20发表于上海

梅斯管理员

#R-CHOP# #弥漫性大B细胞淋巴瘤#

【Leukemia】诊断后两年内复发的DLBCL患者的遗传学和转录组学分析

2024-01-02发表于上海

梅斯管理员

#R-CHOP# #滤泡淋巴瘤# #继发性恶性肿瘤#

【BJH】R-CHOP治疗248例晚期滤泡淋巴瘤的15年随访结果

2023-12-17发表于上海

xiongliangxl

#R-CHOP#

ESMO 2022：奥布替尼联合R-CHOP治疗既往未经治疗的non-GCB DLBCL患者的疗效和安全性

2022-09-13

xiongliangxl

#R-CHOP#

J Clin Oncol：3期| 来那度胺联合R-CHOP方案治疗ABC型DLBCL的疗效和安全性

2021-04-28

xiongliangxl

#R-CHOP#

JCO：来那度胺+R-CHOP联合治疗未能显著改善ABC型DLBCL的PFS

2021-02-26

xiongliangxl

#R-CHOP#

J Clin Oncol：R-CHOP方案+来那度胺可进一步改善新确诊DLBCL患者预后

2021-02-12

xiongliangxl

#R-CHOP#

JCO：来那度胺联合R-CHOP治疗可延长未经治疗的弥漫性大B细胞淋巴瘤患者的生存期

2021-02-11

xiongliangxl

#R-CHOP#

Blood：采用R-CHOP治疗的原发性纵隔大B细胞淋巴瘤(PMBCL) 的预后

2020-07-14

xiongliangxl

#R-CHOP#

Clin cancer research：EPZ-6438联合R-CHOP治疗弥漫性大B细胞淋巴瘤

2020-07-05

智智灵药

#R-CHOP#

Lancet oncol：R-CHOP联合甲氨蝶呤和鞘内化疗治疗新确诊的IVLBCL的疗效和安全性

2020-03-19

xiongliangxl

#R-CHOP#

Lancet：R-CHOP化疗联合利妥昔单抗治疗侵袭性B细胞非霍奇金淋巴瘤

2019-12-22

xiongliangxl

#R-CHOP#

王亮教授：R-CHOP一线治疗DLBCL——一直被挑战，至今从未被超越！

2019-06-26

xiongliangxl

#R-CHOP#

Blood：Venetoclax联合R-CHOP可安全有效治疗弥漫性大B细胞淋巴瘤

2019-03-25

xiongliangxl

#R-CHOP#

Lancet Haematol：R-CHOP作为新确诊晚期滤泡性淋巴瘤患者一线治疗怎么样？

2018-12-14